218 related articles for article (PubMed ID: 10932681)
21. Pharmacological management of obesity.
Hanif MW; Kumar S
Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
[TBL] [Abstract][Full Text] [Related]
22. Treatment of obesity: an update on anti-obesity medications.
Halpern A; Mancini MC
Obes Rev; 2003 Feb; 4(1):25-42. PubMed ID: 12608525
[TBL] [Abstract][Full Text] [Related]
23. Novel anti-obesity drugs.
Proietto J; Fam BC; Ainslie DA; Thorburn AW
Expert Opin Investig Drugs; 2000 Jun; 9(6):1317-26. PubMed ID: 11060745
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
25. Orlistat for obesity.
Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
[No Abstract] [Full Text] [Related]
26. Past, Present, and Future of Pharmacologic Therapy in Obesity.
Rodríguez JE; Campbell KM
Prim Care; 2016 Mar; 43(1):61-7, viii. PubMed ID: 26896200
[TBL] [Abstract][Full Text] [Related]
27. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy of obesity: an update.
Schurgin S; Siegel RD
Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological treatment of obesity.
Mancini MC; Halpern A
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):377-89. PubMed ID: 16767304
[TBL] [Abstract][Full Text] [Related]
30. New drug policy in childhood obesity.
Molnár D
Int J Obes (Lond); 2005 Sep; 29 Suppl 2():S62-5. PubMed ID: 16385755
[TBL] [Abstract][Full Text] [Related]
31. Medical management of obesity.
Berke EM; Morden NE
Am Fam Physician; 2000 Jul; 62(2):419-26. PubMed ID: 10929704
[TBL] [Abstract][Full Text] [Related]
32. [The obesity epidemics--do diet pills have a place in the treatment?].
Tonstad S; Birkeland KI
Tidsskr Nor Laegeforen; 2000 Jun; 120(17):1997-2001. PubMed ID: 11008533
[TBL] [Abstract][Full Text] [Related]
33. Drug Insight: appetite suppressants.
Bray GA
Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):89-95. PubMed ID: 16265126
[TBL] [Abstract][Full Text] [Related]
34. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.
Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT
Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247
[TBL] [Abstract][Full Text] [Related]
35. Drug treatment of obesity.
Bray GA
Rev Endocr Metab Disord; 2001 Oct; 2(4):403-18. PubMed ID: 11725727
[TBL] [Abstract][Full Text] [Related]
36. Regulation of food intake and the development of anti-obesity drugs.
Chen Y
Drug Discov Ther; 2016; 10(2):62-73. PubMed ID: 27063550
[TBL] [Abstract][Full Text] [Related]
37. Influence of eating behaviors on short-term weight loss by orlistat and anorectic agent.
Kim KK; Suh HS; Hwang IC; Ko KD
Eat Behav; 2014 Jan; 15(1):87-90. PubMed ID: 24411757
[TBL] [Abstract][Full Text] [Related]
38. New and emerging drug molecules against obesity.
George M; Rajaram M; Shanmugam E
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in the pharmacological management of obesity.
Carek PJ; Dickerson LM
Drugs; 1999 Jun; 57(6):883-904. PubMed ID: 10400403
[TBL] [Abstract][Full Text] [Related]
40. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men.
Pace DG; Blotner S; Guerciolini R
J Nutr; 2001 Jun; 131(6):1694-9. PubMed ID: 11385055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
